Marga B.V v Dermalogica South Africa (Pty) Ltd (LM022May23) [2023] ZACT 69 (7 September 2023)

Marga B.V v Dermalogica South Africa (Pty) Ltd (LM022May23) [2023] ZACT 69 (7 September 2023)

The Tribunal found that the proposed merger between Marga B.V and Dermalogica South Africa (Pty) Ltd does not substantially prevent or lessen competition in any relevant market. However, the Tribunal determined that public interest considerations warranted the imposition of conditions. These conditions include commitments to education and training for HDP women and youth, supplier development for SMMEs, and the establishment of the Dermalogica Entrepreneurial Ownership Programme. The Tribunal further imposed monitoring and reporting obligations to ensure compliance. The merger was approved subject to these conditions, with the Tribunal retaining the authority to revoke approval in the...

Citation
[2023] ZACT 69
Parties
Applicant: Marga B.V; Respondent: Dermalogica South Africa (Pty) Ltd
Court
Competition Tribunal
Jurisdiction
South Africa
Judgment Date
7 September 2023
Case Number
LM022May23
Procedural Posture
Merger Application / Final Determination
Outcome
Merger approved subject to public interest conditions and compliance monitoring.
Judges
S Goga, A Ndoni, F Tregenna
Legal Topics
Merger Clearance, Public Interest Conditions, Hdp Empowerment, Supplier Development, Education and Training, Monitoring and Compliance
Competition Law Merger Clearance Public Interest Conditions Hdp Empowerment Supplier Development Education and Training Monitoring and Compliance

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 3 Authorities cited 1 Party arguments 2
Sign in to unlock

Parties

Marga B.V

Applicant

Dermalogica South Africa (Pty) Ltd

Respondent

Procedural Posture

Merger Application / Final Determination

Legal Issues

  1. 1 Whether the proposed merger between Marga B.V and Dermalogica South Africa (Pty) Ltd should be approved under section 16(2)(b) of the Competition Act.
  2. 2 Whether the merger should be subject to public interest conditions relating to historically disadvantaged persons (HDPs), youth, and SMMEs.
  3. 3 Whether the proposed education, training, entrepreneurial, and supplier development commitments are sufficient to address competition and public interest concerns.

Ratio Decidendi

The Tribunal found that the proposed merger between Marga B.V and Dermalogica South Africa (Pty) Ltd does not substantially prevent or lessen competition in any relevant market. However, the Tribunal determined that public interest considerations warranted the imposition of conditions. These conditions include commitments to education and training for HDP women and youth, supplier development for SMMEs, and the establishment of the Dermalogica Entrepreneurial Ownership Programme. The Tribunal further imposed monitoring and reporting obligations to ensure compliance. The merger was approved subject to these conditions, with the Tribunal retaining the authority to revoke approval in the...

Court Disposition

Merger approved subject to public interest conditions and compliance monitoring.

Orders

  • The merger between Marga B.V and Dermalogica South Africa (Pty) Ltd is approved in terms of section 16(2)(b) of the Competition Act.
  • A Merger Clearance Certificate is to be issued in terms of Competition Tribunal Rule 35(5)(a).